表紙
市場調査レポート

次世代シークエンシング (NGS) サービスの欧州市場の予測 〜2020年:技術 (SBS・SBL・SMRT・パイロシークエンシング)・用途・エンドユーザー・疾患別

European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020

発行 MarketsandMarkets 商品コード 342074
出版日 ページ情報 英文 213 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
次世代シークエンシング (NGS) サービスの欧州市場の予測 〜2020年:技術 (SBS・SBL・SMRT・パイロシークエンシング)・用途・エンドユーザー・疾患別 European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020
出版日: 2015年10月13日 ページ情報: 英文 213 Pages
概要

欧州の次世代シークエンシング (NGS) サービスの市場は2015年から2020年にかけて21%のCAGRで推移し、2015年の4億4400万米ドルから、2020年には11億5200万米ドルの規模に成長すると予測されています。この成長は主に、速度とコスト効率、他のプラットフォームと比較したNGSの人気の拡大、遺伝性疾患の発症率の拡大、ゲノミクスの創薬への応用、癌、その他の悪性疾患の発症率の拡大、企業・R&Dセンター・大学間での提携などの要因によって推進されています。

当レポートでは、欧州の次世代シークエンシング (NGS) サービスの市場について調査し、主な技術・用途の定義、市場および術の発展の経緯、主な法規制・認証、顧客の認識に関する調査、市場成長への各種影響因子の分析、技術・用途・疾患区分・エンドユーザー・主要国別の動向と市場規模の推移と予測、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 市場の発展の経緯
  • 市場区分
  • 市場力学
    • 成長推進因子
    • 成長阻害因子
    • 市場機会
    • 課題

第5章 産業動向

  • 価格分析
  • 投資家の分析
  • PESTLE分析

第6章 法規制・認証関連の環境

第7章 顧客の認識に関する分析

第8章 ベンチマークパラメーター・将来の動向

第9章 市場分析:技術別

  • SBS
  • イオン半導体
  • SBL
  • パイロシークエンシング
  • SMRT

第10章 市場分析:用途別

  • 用途 (I)
    • 研究
    • 臨床
  • 用途 (II)
    • RNAシークエンシング
    • ターゲットシークエンシング
    • EXOMEシークエンシング
    • 全ゲノムシークエンシング
    • CHIPシークエンシング
    • メチル化シークエンシング
    • デノボシークエンシング
    • その他

第11章 市場分析:疾患区分別

  • 概要
    • 肺癌
    • 乳癌
    • 前立腺癌
    • 大腸癌
    • その他

第12章 市場分析:エンドユーザー別

  • 研究センター・学術機関・政府機関
  • 病院・診療所
  • 医薬品・バイオテクノロジー企業
  • その他

第13章 地域分析

  • イントロダクション
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • オランダ
  • その他

第14章 競合環境

  • 新製品の投入
  • 政府による資金供給
  • 市場シェア分析

第15章 企業プロファイル

  • BEIJING GENOMICS INSTITUTE (BGI)
  • CEGAT (CENTRE FOR GENOMICS AND TRANSCRIPTOMICS) GMBH
  • DNA VISION SA
  • EUROFINS GENOMICS INC.
  • FEBIT / COMPREHENSIVE BIOMARKER CENTER GMBH (CBC)
  • GENOMNIA SRL
  • ILLUMINA INC.
  • MACROGEN INC.
  • MICROSYNTH AG
  • SEQOMICS
  • SOURCE BIO SCIENCE

第16章 付録

図表

目次
Product Code: BT 3781

The NGS services market in Europe is expected to reach USD 1,152 million by 2020 from USD 444 million in 2015, at a CAGR of 21% from 2015 to 2020. The European NGS services market is segmented on the basis of technology, application, end user, disease type, and country.

The European NGS services market is primarily driven by factors such as faster and cost-efficient sequencing; rising preference of NGS over other platforms; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities. Technological advancements have widened the scope of NGS as they assist in the detection of various tumors, malignancies, and other oncological conditions in the early stages. Cancer genomes are extremely complex and diverse; NGS is used to detect mutations and perform many tests at once in such heterogeneous samples; thus playing an important role in cancer research.

Apart from comprehensive technology, application, end-user, and country-level analysis and market sizing, the report also provides the company profiles which comprise basic views on key players with regard to business overview, service offerings, and developments in this market. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding service offerings, regional focus, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, new services/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Information on the service portfolios of the key players in the European NGS services market. The report analyzes this market by technology, application, end user, disease type, and region
  • NGS Services/Innovations: Insights on R&D activities and new service launches in the European NGS services market
  • Competitive Assessment: In-depth assessment of geographical & business segments and service portfolios of some of the key players in the European NGS services market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various NGS technologies and applications across regions
  • Market Diversification: Information about new services, recent developments, and investments in the European NGS services marke

Table of Contents

1. INTRODUCTION

  • 1.1. OBJECTIVES
  • 1.2. MARKET DEFINITIONS
  • 1.3. MARKET SCOPE

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

  • 4.1. INTRODUCTION
  • 4.2. EVOLUTION
  • 4.3. MARKET SEGMENTATION
  • 4.4. MARKET DYNAMICS
    • 4.4.1. DRIVERS
    • 4.4.2. RESTRAINTS
    • 4.4.3. OPPORTUNITIES
    • 4.4.4. CHALLENGES

5. INDUSTRY INSIGHTS

  • 5.1. PRICING ANALYSIS
  • 5.2. INVESTOR ANALYSIS
  • 5.3. PESTEL ANALYSIS

6. REGULATION AND CERTIFICATION LANDSCAPE

7. CUSTOMER PERCEPTION ANALYSIS

8. BENCHMARK PARAMETERS AND FUTURISTIC TRENDS

9. EUROPEAN NGS SERVICES MARKET, BY TECHNOLOGY

  • 9.1. SBS
  • 9.2. ION SEMICONDUCTOR
  • 9.3. SBL
  • 9.4. PYRO-SEQUENCING
  • 9.5. SMRT

10. EUROPEAN NGS SERVICES MARKET, BY APPLICATION

  • 10.1. APPLICATION (I)
    • 10.1.1. RESEARCH APPLICATIONS
    • 10.1.2. CLINICAL APPLICATIONS
  • 10.2. APPLICATION (II)
    • 10.2.1. RNA-SEQUENCING
    • 10.2.2. TARGETED SEQUENCING
    • 10.2.3. EXOME SEQUENCING
    • 10.2.4. WHOLE GENOME SEQUENCING
    • 10.2.5. CHIP-SEQUENCING
    • 10.2.6. METHYL-SEQUENCING
    • 10.2.7. DE NOVO SEQUENCING
    • 10.2.8. OTHERS

11. EUROPEAN NGS SERVICES MARKET, BY DISEASE TYPE

  • 11.1. OVERVIEW
  • 11.2. ONCOLOGY
    • 11.2.1. LUNG CANCER
    • 11.2.2. BREAST CANCER
    • 11.2.3. PROSTATE CANCER
    • 11.2.4. COLORECTAL CANCER
    • 11.2.5. OTHERS

12. EUROPEAN NGS SERVICES MARKET, BY END USER

  • 12.1. RESEARCH CENTERS, ACADEMIC & GOVERNMENT INSTITUTES
  • 12.2. HOSPITALS & CLINICS
  • 12.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 12.4. OTHERS

13. EUROPEAN NGS SERVICES MARKET, BY GEOGRAPHY

  • 13.1. INTRODUCTION
  • 13.2. U.K.
  • 13.3. GERMANY
  • 13.4. FRANCE
  • 13.5. ITALY
  • 13.6. SPAIN
  • 13.7. NETHERLANDS
  • 13.8. REST OF THE EUROPE (ROE)

14. COMPETITIVE LANDSCAPE

  • 14.1. NEW PRODUCT LAUNCHES
  • 14.2. GOVERNMENT FUNDING
  • 14.3. MARKET SHARE ANALYSIS

15. COMPANY PROFILES

  • 15.1. BEIJING GENOMICS INSTITUTE (BGI)
  • 15.2. CEGAT (CENTRE FOR GENOMICS AND TRANSCRIPTOMICS) GMBH
  • 15.3. DNA VISION SA
  • 15.4. EUROFINS GENOMICS INC.
  • 15.5. FEBIT / COMPREHENSIVE BIOMARKER CENTER GMBH (CBC)
  • 15.6. GENOMNIA SRL
  • 15.7. ILLUMINA INC.
  • 15.8. MACROGEN INC.
  • 15.9. MICROSYNTH AG
  • 15.1. SEQOMICS
  • 15.11. SOURCE BIO SCIENCE

16. APPENDIX

  • 16.1. CERTIFIED NGS SERVICE PROVIDERS IN EUROPE
  • 16.2. MAJOR END USERS OF NGS SERVICES
  • 16.3. RELATED REPORTS

List of Tables

  • TABLE 1: EUROPEAN NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 2: SBS TECHNOLOGY BASED SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 3: ION SEMICONDUCTOR TECHNOLOGY BASED SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 4: SBL TECHNOLOGY-BASED SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 5: PYROSEQUENCING TECHNOLOGY BASED SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 6: SMRT TECHNOLOGY BASED SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 7: EUROPEAN NGS SERVICES MARKET SIZE, BY APPLICATION (I), 2013-2020 (USD MILLION)
  • TABLE 8: NGS SERVICES MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 9: NGS SERVICES MARKET SIZE FOR CLINICAL APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 10: EUROPEAN NGS SERVICES MARKET SIZE, BY APPLICATION (II), 2013-2020 (USD MILLION)
  • TABLE 11: RNA-SEQ SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 12: TARGETED SEQUENCING/GENE PANELS SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 13: EXOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 14: WHOLE GENOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 15: CHIP-SEQ SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 16: METHYL-SEQ SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 17: DE NOVO SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 18: OTHER SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 19: NGS SERVICES MARKET SIZE, BY DISEASE TYPE, 2013-2020 (USD MILLION)
  • TABLE 20: EUROPEAN NGS ONCOLOGY SERVICES MARKET, BY CANCER TYPE, 2013-2020 (USD MILLION)
  • TABLE 21: NGS SERVICES MARKET SIZE FOR LUNG CANCER, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 22: NGS SERVICES MARKET SIZE FOR BREAST CANCER, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 23: NGS SERVICES MARKET SIZE FOR PROSTATE CANCER, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 24: NGS SERVICES MARKET SIZE FOR COLORECTAL CANCER, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 25: NGS SERVICES MARKET SIZE FOR OTHER ONCOLOGY DISEASES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 26: EUROPEAN NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 27: NGS SERVICES MARKET SIZE FOR RESEARCH CENTERS, ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 28: NGS SERVICES MARKET SIZE FOR HOSPITALS & CLINICS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 29: NGS SERVICES MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 30: NGS SERVICES MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 31: EUROPEAN NGS SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 32: EUROPEAN ONCOLOGY NGS SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 33: U.K.: NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 34: U.K.: NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2013-2020 (USD MILLION)
  • TABLE 35: U.K.: NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 36: U.K.: NGS SERVICES MARKET SIZE, BY APPLICATIONS (II), 2013-2020 (USD MILLION)
  • TABLE 37: U.K.: NGS ONCOLOGY SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 38: GERMANY: NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 39: GERMANY: NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2013-2020 (USD MILLION)
  • TABLE 40: GERMANY: NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 41: GERMANY: NGS SERVICES MARKET SIZE, BY APPLICATIONS (II), 2013-2020 (USD MILLION)
  • TABLE 42: GERMANY: ONCOLOGY NGS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 43: FRANCE: NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 44: FRANCE: NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2013-2020 (USD MILLION)
  • TABLE 45: FRANCE: NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 46: FRANCE: NGS SERVICES MARKET SIZE, BY APPLICATIONS (II), 2013-2020 (USD MILLION)
  • TABLE 47: FRANCE: ONCOLOGY NGS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 48: ITALY: NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 49: ITALY: NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2013-2020 (USD MILLION)
  • TABLE 50: ITALY: NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 51: ITALY: NGS SERVICES MARKET SIZE, BY APPLICATIONS, (II) 2013-2020 (USD MILLION)
  • TABLE 52: ITALY: ONCOLOGY NGS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 53: SPAIN: NGS SERVICES MARKET, BY TECHNOLOGY SIZE, 2013-2020 (USD MILLION)
  • TABLE 54: SPAIN: NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2013-2020 (USD MILLION)
  • TABLE 55: SPAIN: NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 56: SPAIN: NGS SERVICES MARKET SIZE, BY APPLICATIONS (II) 2013-2020 (USD MILLION)
  • TABLE 57: SPAIN: ONCOLOGY NGS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 58: NETHERLANDS: NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 59: NETHERLANDS: NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2013-2020 (USD MILLION)
  • TABLE 60: NETHERLANDS: NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 61: NETHERLANDS: NGS SERVICES MARKET SIZE, BY APPLICATIONS (II), 2013-2020 (USD MILLION)
  • TABLE 62: NETHERLANDS: ONCOLOGY NGS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 63: ROE: NGS SERVICES MARKET, BY TECHNOLOGY SIZE, 2013-2020 (USD MILLION)
  • TABLE 64: ROE: NGS SERVICES MARKET SIZE, BY APPLICATIONS(I), 2013-2020 (USD MILLION)
  • TABLE 65: ROE: NGS SERVICES MARKET SIZE, BY END-USER , 2013-2020 (USD MILLION)
  • TABLE 66: ROE: NGS SERVICES MARKET SIZE, BY APPLICATIONS (II), 2013-2020 (USD MILLION)
  • TABLE 67: ROE: ONCOLOGY NGS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)

List of Figures

  • FIGURE 1: EUROPE NGS SERVICES MARKET SIZE, 2015-2020 (USD MILLION)
  • FIGURE 2: EUROPEAN NGS SERVICES: CUSTOMER SEGMENTATION, 2015
  • FIGURE 3: EUROPEAN NGS SERVICES: COUNTRY-WISE MARKET SHARE, 2015
  • FIGURE 4: EUROPEAN NGS SERVICES MARKET SIZE, 2014-2020 (USD MILLION)
  • FIGURE 5: PRICING ANALYSIS
  • FIGURE 6: EUROPEAN NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2015 & 2020 (USD MILLION)
  • FIGURE 7: EUROPEAN NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2011-2020 (USD MILLION)
  • FIGURE 8: EUROPEAN NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2015 & 2020 (USD MILLION)
  • FIGURE 9: EUROPEAN NGS SERVICES MARKET SIZE, BY APPLICATION (II), 2015 & 2020 (USD MILLION)
  • FIGURE 10: EUROPEAN NGS SERVICES MARKET SIZE, BY DISEASE TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 11: EUROPEAN NGS SERVICES MARKET SIZE, BY END USER, 2011-2020 (USD MILLION)
  • FIGURE 12: MARKET SHARE IN THE EUROPEAN NGS SERVICES MARKET (2014)
Back to Top